263
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Very-Early Onset Chronic Active Colitis with Heterozygous Variants in LRBA1 and CARD11, a Case of “Immune TOR-Opathies”

ORCID Icon, , , &
Pages 297-306 | Received 18 May 2022, Accepted 31 May 2022, Published online: 24 Jun 2022

References

  • Russo P. Chapter 14. The gastrointestinal tract. In: Husain AN, Stoker JT, Dehner LP, editors. Pediatric pathology. Wolters Kluwer; 2016, p. 581–653.
  • Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307–17. doi:10.1038/nature10209. PMID: 21677747; PMCID: PMC3204665.
  • Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut. 2013;62(12):1795–805. doi:10.1136/gutjnl-2012-303956. PMID: 24203055.
  • Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007.e3. Nov doi:10.1053/j.gastro.2014.07.023. Epub 2014 Jul 21. PMID: 25058236; PMCID: PMC5376484.
  • Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, Pauly-Hubbard H, Martinez A, Maurer K, Soong J, Rappaport E, et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology. 2015;149(6):1415–24. doi:10.1053/j.gastro.2015.07.006. Epub 2015 Jul 17. PMID: 26193622; PMCID: PMC4853027.
  • Jung S, Gámez-Díaz L, Proietti M, Grimbacher B. Immune TOR-opathies. Front Immunol. 2018;9:966. doi: 10.3389/fimmu.2018.00966. PMID: 29867948; PMCID: PMC5954032.
  • Conrad MA, Carreon CK, Dawany N, Russo P, Kelsen JR. Distinct histopathological features at diagnosis of very early onset inflammatory bowel disease. J Crohns Colitis. 2019;13(5):615–25. doi:10.1093/ecco-jcc/jjy212. PMID: 30551128; PMCID: PMC6486490.
  • Lopez-Herrera G, Tampella G, Pan-Hammarström Q, Herholz P, Trujillo-Vargas CM, Phadwal K, Simon AK, Moutschen M, Etzioni A, Mory A, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90(6):986–1001. Jun 81001. doi:10.1016/j.ajhg.2012.04.015. Epub 2012 May 17. PMID: 22608502; PMCID: PMC3370280.
  • Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, Raddaoui E, Almomen AK, Al-Muhsen S, Geha RS, et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol. 2012;130(2):481–8.e2. doi:10.1016/j.jaci.2012.05.043. Epub 2012 Jun 19. PMID: 22721650; PMCID: PMC3582381.
  • Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, Zhang Y, Liu Z, Fritz JM, Marsh R, et al. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436–40. doi:10.1126/science.aaa1663. PMID: 26206937.
  • Murphy K, Travers P, Walport M, Janeway C. 2017. Janeway’s immunobiology. New York: Garland Science.
  • Crowley E, Warner N, Pan J, Khalouei S, Elkadri A, Fiedler K, Foong J, Turinsky AL, Bronte-Tinkew D, Zhang S, et al. Prevalence and clinical features of inflammatory bowel diseases associated with monogenic variants, identified by whole-exome sequencing in 1000 children at a single center. Gastroenterology. 2020;158(8):2208–20. doi:10.1053/j.gastro.2020.02.023. Epub 2020 Feb 19. PMID: 32084423; PMCID: PMC7283012.
  • Serwas NK, Kansu A, Santos-Valente E, Kuloğlu Z, Demir A, Yaman A, Gamez Diaz LY, Artan R, Sayar E, Ensari A, et al. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis. 2015;21(1):40–7. doi:10.1097/MIB.0000000000000266. PMID: 25479458.
  • Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, Morio T, Worth AJJ, Blessing J, Van de Veerdonk F, et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016;137(1):223–30. doi:10.1016/j.jaci.2015.09.025. PMID: 26768763.
  • Kolukısa B, Barış S. Primary immune regulatory disorders and targeted therapies. Turk J Haematol. 2021;38(1):1–14. doi:10.4274/tjh.galenos.2021.2020.0724. Epub 2021 Jan 14. PMID: 33442967; PMCID: PMC7927447.
  • National Center for Biotechnology Information. ClinVar; [VCV000287150.24]. [accessed 2022 May 5]. https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000287150.24.
  • Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova JL, Cunningham-Rundles C. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220 doi:10.3389/fimmu.2016.00220. PMID: 27379089; PMCID: PMC4903998.
  • Bertin J, Wang L, Guo Y, Jacobson MD, Poyet JL, Srinivasula SM, Merriam S, DiStefano PS, Alnemri ES. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem. 2001;276(15):11877–82. doi:10.1074/jbc.M010512200. Epub 2001 Jan 12. PMID: 11278692.
  • Dorjbal B, Stinson JR, Ma CA, Weinreich MA, Miraghazadeh B, Hartberger JM, Frey-Jakobs S, Weidinger S, Moebus L, Franke A, et al. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease. J Allergy Clin Immunol. 2019;143(4):1482–95. doi:10.1016/j.jaci.2018.08.013.
  • Brohl AS, Stinson JR, Su HC, Badgett T, Jennings CD, Sukumar G, Sindiri S, Wang W, Kardava L, Moir S, et al. Germline CARD11 mutation in a patient with severe congenital B cell lymphocytosis. J Clin Immunol. 2015;35(1):32–46. doi:10.1007/s10875-014-0106-4.
  • Ma CA, Stinson JR, Zhang Y, Abbott JK, Weinreich MA, Hauk PJ, Reynolds PR, Lyons JJ, Nelson CG, Ruffo E, Dorjbal B, et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet. 2017;49(8):1192–201. doi:10.1038/ng.3898. Epub 2017 Jun 19. Erratum in: Nat Genet. 2017 Oct 27;49(11):1661. PMID: 28628108; PMCID: PMC5664152.
  • Yamamoto-Furusho JK, Fonseca-Camarillo G, Furuzawa-Carballeda J, Sarmiento-Aguilar A, Barreto-Zuñiga R, Martínez-Benitez B, Lara-Velazquez MA. Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease. J Inflamm. 2018;15(1):13. doi:10.1186/s12950-018-0189-4. PMID: 30008619; PMCID: PMC6042317.
  • National Center for Biotechnology Information. ClinVar; [VCV000489270.3]. [accessed 2022 May 6]. https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000489270.3
  • Meitlis I, Allenspach EJ, Bauman BM, Phan IQ, Dabbah G, Schmitt EG, Camp ND, Torgerson TR, Nickerson DA, Bamshad MJ, et al. Multiplexed functional assessment of genetic variants in CARD11. Am J Hum Genet. 2020;107(6):1029–43. doi:10.1016/j.ajhg.2020.10.015. Epub 2020 Nov 16. PMID: 33202260; PMCID: PMC7820631.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.